-
Onconova Therapeutics to Provide Corporate Update
Post on 8/7/18
-
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part III
Post on 8/17/18
-
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part II
Post on 8/14/18
-
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part I
Post on 8/9/18
-
Krystal Biotech Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Post on 8/6/18
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 8/2/18
-
Marinus Pharmaceuticals Provides Business Update
Post on 8/2/18
-
Marks & Spencer Expands Partnership with First Insight
Post on 8/1/18
-
AMETEK Acquires Motec GmbH
Post on 7/31/18
-
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 7/30/18
-
Johnson & Johnson Consumer To Acquire Zarbee's
Post on 7/30/18
-
Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split
Post on 7/27/18
-
Nabriva Therapeutics Prices Public Offering of Ordinary Shares of Approximately $50M
Post on 7/26/18
-
Zynerba Pharmaceuticals Prices Public Offering of Common Stock
Post on 7/22/18
-
Idera Pharmaceuticals Provides Update On Corporate Strategy And Outlook
Post on 7/19/18
-
New Partnership Between Gastrologix and Stratis Medical Offer GI Practices a Smart Choice
Post on 7/19/18
-
OhioHealth and Select Medical Expand Joint Venture to Operate Physical Therapy Centers in Central Ohio
Post on 7/12/18
-
Azalea Health Announces Partnership with Iron Bridge for All Public Health Submissions
Post on 7/9/18
-
Is Inovio Pharmaceuticals, Inc. a Buy?
Post on 7/9/18
-
Neuronetics Closes IPO
Post on 7/2/18
-
Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal
Post on 7/2/18
-
Eight Genesis HealthCare Centers Earn 2018 Bronze National Quality Awards
Post on 6/27/18
-
Saladax Signs Licensing Agreement with Janssen
Post on 6/26/18
-
Ebb Therapeutics Wins Silver at the Prestigious MDEA Awards
Post on 6/26/18
-
Interview with Scott Applebaum, President of Context Therapeutics - Part III
Post on 7/13/18
Pittsburgh
